1. 226 Genetic variations of NF-κB2 are associated with overall survival of non-small cell lung cancer (NSCLC) patients. (September 2015) Authors: Dimitrakopoulos, F.I.; Antonacopoulou, A.; Kottorou, A.; Marousi, S.; Koukourikou, I.; Panagopoulos, N.; Scopa, C.; Papadaki, H.; Dougenis, D.; Kalofonos, H. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Complex phenotype in a C9ORF72‐positive patient with high‐titer anti‐glutamic acid decarboxylase antibodies: neuroimmunology meets neurogenetics. (6th May 2019) Authors: Varvaressos, S.; Breza, M.; Marousi, S.; Printzou, M.; Georgoulis, A.; Papageorgiou, E.; Kartanou, C.; Karadima, G.; Tagaris, G.; Koutsis, G.; Tzartos, J. S. Journal: European journal of neurology Issue: Volume 26:Number 7(2019) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety. (11th January 2013) Authors: Marousi, S.; Karkanis, I.; Kalamatas, T.; Travasarou, M.; Paterakis, G.; Karageorgiou, C. E. Journal: Acta neurologica Scandinavica Issue: Volume 128:Number 1(2013:Jul.) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗